abstract |
SMALL MOLECULE INHIBITORS OF EGFR AND P13K This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a quinazoline structure or a quinoline structure which function as dual inhibitors of EGFR proteins and P13K proteins, and their use as therapeutics for the treatment of cancer and other diseases. |